Skip to content

Clinical trials

Amyloidosis trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyloidosis Country / region: Portugal Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20082
20132
20141
20151
20181
20194
20203
20212
20221
20231
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting6
Active, not recruiting2
Enrolling by invitation2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alnylam Pharmaceuticals9
Ionis Pharmaceuticals, Inc.5
Pfizer3
Eidos Therapeutics, a BridgeBio company2
Akcea Therapeutics1
Intellia Therapeutics1
Prothena Biosciences Limited1
Prothena Biosciences Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyloidosis23
Amyloid Neuropathies, Familial10
Cardiomyopathies8
Polyneuropathies7
Amyloidosis, Familial5
Alzheimer Disease4
Amyloid Neuropathies2
Heart Diseases2

Trials

Showing 26 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.